Age-dependent association of polymorphisms in the promoter and 5′-untranslated region of the norepinephrine transporter gene with generalized anxiety disorder

• Published in: Journal of affective disorders 2020-06, Vol.270, p.124-130
• Main Authors: Chang, Hsin-An, Fang, Wen-Hui, Tzeng, Nian-Sheng, Liu, Yia-Ping, Shyu, Jia-Fwu, Wan, Fang-Jung, Huang, San-Yuan, Chang, Tieh-Ching, Chang, Chuan-Chia
• Format: Article
• Language: English
• Subjects: 5' Untranslated Regions - genetics; Adult; Age-dependent effect; Aged; Alleles; Anxiety Disorders - genetics; Generalized anxiety disorder (GAD); Genotype; Haplotype; Humans; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins - genetics; Norepinephrine transporter (NET) gene; Polymorphism, Single Nucleotide - genetics; Promoter Regions, Genetic; Single-nucleotide polymorphism (SNP); Young Adult
• ISSN: 0165-0327; 1573-2517
• DOI: 10.1016/j.jad.2020.03.059

•We found an age-specific association of NET rs2397771-rs168924-rs2242446 with GAD.•In younger age groups, rs168924 G allele homozygotes had the lowest rate of GAD.•However, the opposite pattern was found with rs168924 in older age groups.•Younger participants with 2 GGT haplotype copies had the lowest incidence of GAD.•Also, an inverse pattern was found with the same haplotype in older subjects. Norepinephrine transporter (NET), which regulates synaptic norepinephrine for noradrenergic signaling, is involved in the pathogenesis of anxiety, while expression of the NET gene differs at different ages. Here, we examine whether genetic variants in the NET gene are associated, in an age-specific manner, with increased risk of generalized anxiety disorder (GAD), one of the most disabling anxiety disorders. Three common single-nucleotide polymorphisms (SNPs) in the promoter (rs168924: A/G; rs2242446: T/C) and 5′-untranslated region (5′-UTR) (rs2397771: G/C) of the NET gene were genotyped in 2,317 Han-Chinese participants (791 GAD patients and 1,526 controls; age: 20–65). Potential confounding factors, such as gender, stress levels and psychiatric comorbidities, were included as covariates. An interaction between age and NET genotypes and haplotypes was found for the risk of GAD. In the younger participants, rs168924 minor allele G homozygotes had the lowest incidence of GAD; however, older subjects displayed an inverse pattern, with homozygous G/G carriers presenting the highest prevalence of GAD. Additionally, younger individuals carrying 2 copies of the GGT haplotype composed of rs2397771-rs168924-rs2242446 had the lowest rate of GAD. However, those with 2 copies of the same haplotype exhibited the highest risk of GAD in the older groups. Only 3 common SNPs in the promoter and 5′-UTR of the NET gene were analyzed. Our findings are the first to demonstrate that potentially functional SNPs in the NET promoter and 5′-UTR are associated with an increased risk of GAD, and that such associations are determined in an age-specific way.